Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Interest Coverage Ratio (2016 - 2025)

Northwest Biotherapeutics' Interest Coverage Ratio history spans 16 years, with the latest figure at 12.56 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 12.56 for Q4 2025, up 2.72% from a year ago — trailing twelve months through Dec 2025 was 1.52 (up 33.07% YoY), and the annual figure for FY2025 was 1.52, up 33.07%.
  • Interest Coverage Ratio for Q4 2025 was 12.56 at Northwest Biotherapeutics, up from 5.46 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 12.56 in Q4 2025 to a low of 15.37 in Q2 2021.
  • The 5-year median for Interest Coverage Ratio is 10.35 (2022), against an average of 8.09.
  • The sharpest move saw Interest Coverage Ratio plummeted 116.05% in 2021, then surged 200.27% in 2024.
  • Year by year, Interest Coverage Ratio stood at 9.26 in 2021, then tumbled by 60.79% to 14.89 in 2022, then grew by 18.11% to 12.19 in 2023, then surged by 200.27% to 12.23 in 2024, then grew by 2.72% to 12.56 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 12.56, 5.46, and 8.09 for Q4 2025, Q3 2025, and Q2 2025 respectively.